Prescribing for Diabetes in England 2008/09 - 2018/19Official statistics
- Publication Date:
- 7 Nov 2019
- Geographic Coverage:
- Geographical Granularity:
- Clinical Commissioning Groups, Country
- Date Range:
- 01 Apr 2008 to 31 Mar 2019
This publication reports on trends in the prescribing of medicines for the treatment and monitoring of diabetes in England from 2008/09 to 2018/19.
12.5% of the total cost of prescribing in 2018/19 was for the treatment of diabetes
The cost of prescribing for antidiabetic drugs has increased more than for other categories of drugs used in diabetes
The average cost of diabetes drugs prescribed per patient with diabetes was £327.78 in 2018/19
View the full results and graphical visualisations of the data in the Results section
Please note, data for 2014/15 to 2018/19 has been revised slightly to match changes in how the prescription data is processed and held by the NHS BSA. Users should always use data from the latest publication where available.
Cost per patient for a CCG may be affected by General Practices being excluded from the QOF diabetes register (for example, Kernow CCG). A list of those practices where validators have requested that they are excluded from the QOF figures can be found by filtering on the ‘NHS Digital Comment / Action’ column of the ‘QOF 2018-19: Practice validation comments’ file published here.
NHS BSA, Quality and Outcomes Framework